A Phase 1, Randomized, Open Label, Single Dose, 2-Period Crossover Study To Evaluate The Effect Of Food On The Pharmacokinetics Of Tofacitinib Modified Release (MR) 11 Mg Tablets In Healthy Western And Japanese Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2016
At a glance
- Drugs Tofacitinib (Primary)
- Indications Ankylosing spondylitis; Atopic dermatitis; Crohn's disease; Dry eyes; Juvenile rheumatoid arthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 11 Mar 2016 Results from this and other phase I trial, published in the Journal of Clinical Pharmacology.
- 09 Jul 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
- 09 Jun 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2014 to 1 Jun 2014.